Semler Scientific (SMLR) Competitors $28.38 -0.81 (-2.77%) Closing price 04:00 PM EasternExtended Trading$28.42 +0.04 (+0.16%) As of 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMLR vs. NVCR, SSII, CDRE, BLFS, ESTA, MDXG, PLSE, INMD, IRMD, and BBNXShould you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include NovoCure (NVCR), SS Innovations International (SSII), Cadre (CDRE), BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), iRadimed (IRMD), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry. Semler Scientific vs. Its Competitors NovoCure SS Innovations International Cadre BioLife Solutions Establishment Labs MiMedx Group Pulse Biosciences InMode iRadimed Beta Bionics NovoCure (NASDAQ:NVCR) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings, media sentiment and risk. Do insiders & institutionals believe in NVCR or SMLR? 84.6% of NovoCure shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 5.5% of NovoCure shares are owned by company insiders. Comparatively, 16.4% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer NVCR or SMLR? In the previous week, Semler Scientific had 13 more articles in the media than NovoCure. MarketBeat recorded 24 mentions for Semler Scientific and 11 mentions for NovoCure. NovoCure's average media sentiment score of 1.16 beat Semler Scientific's score of 0.21 indicating that NovoCure is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NovoCure 4 Very Positive mention(s) 4 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Semler Scientific 1 Very Positive mention(s) 2 Positive mention(s) 20 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings and valuation, NVCR or SMLR? Semler Scientific has lower revenue, but higher earnings than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNovoCure$605.22M2.35-$168.63M-$1.56-8.15Semler Scientific$56.29M7.47$40.90M$2.4311.68 Which has more volatility & risk, NVCR or SMLR? NovoCure has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500. Is NVCR or SMLR more profitable? Semler Scientific has a net margin of 86.20% compared to NovoCure's net margin of -27.13%. Semler Scientific's return on equity of 43.84% beat NovoCure's return on equity.Company Net Margins Return on Equity Return on Assets NovoCure-27.13% -47.74% -13.79% Semler Scientific 86.20%43.84%32.88% Do analysts prefer NVCR or SMLR? NovoCure currently has a consensus target price of $28.79, indicating a potential upside of 126.30%. Semler Scientific has a consensus target price of $81.75, indicating a potential upside of 188.05%. Given Semler Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Semler Scientific is more favorable than NovoCure.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NovoCure 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 SummarySemler Scientific beats NovoCure on 13 of the 17 factors compared between the two stocks. Get Semler Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMLR vs. The Competition Export to ExcelMetricSemler ScientificMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$420.31M$6.69B$5.75B$10.28BDividend YieldN/A1.20%5.72%4.60%P/E Ratio11.6825.8474.9926.41Price / Sales7.47173.23456.1088.49Price / Cash6.5222.1825.8129.91Price / Book1.144.9413.256.28Net Income$40.90M$176.38M$3.29B$270.38M7 Day Performance0.32%4.96%0.46%2.69%1 Month Performance-16.13%6.43%4.59%5.98%1 Year Performance9.49%10.59%73.41%25.93% Semler Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMLRSemler Scientific2.9817 of 5 stars$28.38-2.8%$81.75+188.1%+12.6%$420.31M$56.29M11.68120NVCRNovoCure4.3432 of 5 stars$12.60+2.6%$28.79+128.5%-34.6%$1.37B$605.22M-8.081,488News CoverageSSIISS Innovations InternationalN/A$6.14-12.3%N/AN/A$1.36B$20.65M0.004Positive NewsGap UpHigh Trading VolumeCDRECadre2.8702 of 5 stars$31.83-0.5%$31.50-1.0%-9.4%$1.30B$567.56M33.862,284Positive NewsAnalyst UpgradeBLFSBioLife Solutions2.8007 of 5 stars$26.22-0.9%$31.29+19.3%+1.6%$1.27B$93.47M-218.48440Positive NewsESTAEstablishment Labs2.2812 of 5 stars$38.24-2.0%$56.50+47.8%-15.2%$1.13B$166.02M-12.541,018Positive NewsMDXGMiMedx Group3.5089 of 5 stars$7.17+0.4%$12.00+67.4%+11.6%$1.06B$348.88M34.14870Positive NewsPLSEPulse Biosciences4.3351 of 5 stars$15.04-0.5%$22.00+46.3%-21.6%$1.02B$700K-14.32140News CoveragePositive NewsInsider TradeGap UpINMDInMode3.0625 of 5 stars$15.28+2.0%$18.04+18.1%-13.0%$946.87M$401.56M6.19480Positive NewsIRMDiRadimed4.8025 of 5 stars$71.85-0.2%$72.00+0.2%+47.0%$915.36M$73.24M44.35110Short Interest ↓BBNXBeta Bionics1.0204 of 5 stars$23.13+14.5%$22.56-2.5%N/A$878.10M$65.12M0.00294High Trading Volume Related Companies and Tools Related Companies NovoCure Alternatives SS Innovations International Alternatives Cadre Alternatives BioLife Solutions Alternatives Establishment Labs Alternatives MiMedx Group Alternatives Pulse Biosciences Alternatives InMode Alternatives iRadimed Alternatives Beta Bionics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMLR) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semler Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
